NCT01883986

Brief Summary

The aims of this project are to assess the feasibility of recruiting patients and delivering a nurse-led telephone based palliative care intervention for patients with newly diagnosed lung cancer and to assess if among patients with newly diagnosed lung cancer, the investigators can estimate the effect of a nurse-led telephone based palliative care intervention on quality-of-life, symptom burden and patient satisfaction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable lung-cancer

Timeline
Completed

Started Feb 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 18, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 21, 2013

Completed
8 months until next milestone

Study Start

First participant enrolled

February 1, 2014

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

January 31, 2017

Completed
Last Updated

January 31, 2017

Status Verified

December 1, 2016

Enrollment Period

1.8 years

First QC Date

June 18, 2013

Results QC Date

October 7, 2016

Last Update Submit

December 6, 2016

Conditions

Keywords

palliative care

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline in Functional Assessment of Cancer Therapy-Lung Total Outcome Index Score at 3 Months

    Patient Quality of Life including symptoms as measured by the FACT-L (Functional Assessment of Cancer Therapy-Lung Scale). The FACT-L outcome measure reported is the mean change in the TOI subscale (Total Outcome Index) of the instrument, computed as the differences between final and baseline visit scores. The TOI subscale range is 0-84 with a higher score indicating a better quality of life.

    Baseline and 3 months

Secondary Outcomes (3)

  • Change From Baseline in Patient Satisfaction of Care at 3 Months

    Baseline and 3 months

  • Change in Baseline Quality of Clinician Communication at 3 Months

    Baseline and 3 months

  • Change From Baseline in Clinician Knowledge of Patient Preferences at 3 Months

    Baseline and 3 months

Study Arms (2)

Intervention

EXPERIMENTAL

This is a 3 month nurse-led telephone based program integrating palliative care into usual oncologic care for patients diagnosed within 2 months of any type and stage of lung cancer.

Behavioral: Palliative Care

Usual Care

NO INTERVENTION

Subjects randomized to usual care will receive medical oncology, radiation oncology, pulmonary, CT surgery as indicated by the type of cancer. At the completion of 3 months of usual care, subjects are invited to join the intervention arm.

Interventions

Palliative CareBEHAVIORAL

Care delivered by a nurse including symptom assessment and management, patient education on lung cancer and treatment options , discussion and communication about preferences for care, psychosocial assessment including referrals to ancillary services such as social services and spiritual care as requested by the patient.

Intervention

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed at the Puget Sound Health Care System with a primary diagnosis of lung cancer,
  • any cell type or stage,
  • diagnosed within 8 weeks of study enrollment.
  • Must have telephone access,
  • ability of understand English and
  • provide informed consent.

You may not qualify if:

  • Patients not eligible to participate in the study include those who are inpatients prior to randomization,
  • those who are under the care of palliative care or hospice at the time of randomization,
  • those who have severe mental health disorders,
  • those who are unable to speak directly with the nurse over the telephone,
  • or those that have the inability to provide informed consent. Investigators will recruit individuals (n=40) with lung cancer over a 12 month period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Puget Sound Health Care System Seattle Division, Seattle, WA

Seattle, Washington, 98108, United States

Location

MeSH Terms

Conditions

Lung Neoplasms

Interventions

Palliative Care

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Results Point of Contact

Title
Lynn F. Reinke, PhD, ARNP
Organization
VA Puget Sound Health Care System

Study Officials

  • Lynn F. Reinke, PhD ARNP

    VA Puget Sound Health Care System Seattle Division, Seattle, WA

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2013

First Posted

June 21, 2013

Study Start

February 1, 2014

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

January 31, 2017

Results First Posted

January 31, 2017

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will not share

Locations